423-920-8

Applied Filters:

Keyword:'423-920-8'

Showing 1-8 of 8 results for "423-920-8" within Technical Documents

Drug Discovery Products & Services - Volume 1, 2014

yeast 14-112 3 12-423, 12-529 Casein Kinase 1γ1, active 14-711 3 12-423, 12-529 Casein Kinase 1γ2, active 14-712 3 12-423, 12-529 Casein Kinase 1γ3, active 14-713 3 12-423, 12-529 Casein

Calbiochem Biologics 29.3

selective, ATP-competitive inhibitor of CDK1/cyclin B, CDK5/p35, and GSK-3 (IC50 = 700 nM 1.5 µM, and 920 nM, respectively). Purity: ≥95% by HPLC. Cat. No. 128135 5 mg Ref.: Mettey, Y., et al. 2003. J.

Biologics 28.1

indolin-2-one class of receptor tyrosine kinase (RTK) inhibitor [IC50 = 70 nM for VEGF-R2 (KDR/Flk-1), 920 nM for PDGF-Rb, 4.92 µM for p60c-src, and 13.3 µM for FGF-R1]. The inhibition is suggested to be competitive

Bioreactor Systems for Bone Tissue Engineering

Orthop Relat Res (329), 300, 1996. 3. Langer, R., and Vacanti, J.P. Tissue engineering. Science 260, 920, 1993. 4. Drosse, I., et al. Tissue engineering for bone defect healing: an update on a multi-component

XP725 Worksheet for Lot Number 071M4826

4 1 4 LRRK2 (PARK8) L3044 917 5 4 1 5 MRP1 M9192 918 5 4 1 6 MRP1 M9192 919 5 4 1 7 MRP2 M3692 920 5 4 1 8 MRP2 M3692 921 5 4 2 1 aMSH M0939 922 5 4 2 2

Inhibitor Sourcebook 3rd Edition

mTORC2, respectively). It inhibits ATR and ATM only at much higher concentrations (IC50 = 850 and 920 nM, respectively) and exhibits little activity towards a panel of more than 40 other kinases even at

Halal Certificate

FCC, FG W276200 A52411 HC-22SIDX12 919. MYRISTIC ACID 95%, FCC, FG W276405 A16221 HC-22SILV73 920. MYRISTIC ACID NATURAL W276413 B56499 HC-22SIGA59 921. N-Amyl Octanoate W207918 C32917 HC-22SIWR18

Halal Certificate

FCC, FG W276200 A52411 HC-23SIJM90 919. MYRISTIC ACID 95%, FCC, FG W276405 A16221 HC-23SI6Z52 920. MYRISTIC ACID NATURAL W276413 B56499 HC-23SIRH38 921. N-Amyl Octanoate W207918 C32917 HC-23SIJQ96